Digitale Bibliotheek
Sluiten Bladeren door artikelen uit een tijdschrift
 
Zoeken naar met titel:
ABCDEFGHIJKLMNOPQRSTUVWXYZ

     Tijdschrift beschrijving
       Alle jaargangen van het bijbehorende tijdschrift
         Alle afleveringen van het bijbehorende jaargang
                                       Alle artikelen van de bijbehorende aflevering
 
                             145 gevonden resultaten
nr titel auteur tijdschrift jaar jaarg. afl. pagina('s) type
1 Acinetobacter epidemiology and typing 1997
 3 S2 p. 213-216
4 p.
 artikel
2 Advances in herpes virus infections 1997
 3 S2 p. 35-36
2 p.
 artikel
3 Advances in HIV 1997
 3 S2 p. 256-262
7 p.
 artikel
4 Antibiotic resistance in Gram–negative bacteria 1997
 3 S2 p. 294-299
6 p.
 artikel
5 Antibiotic resistance in otitis media: Clinical problem or hypothetical risk? 1997
 3 S2 p. 16-17
2 p.
 artikel
6 Antibiotics in the hospital setting: Surveillance, resistance, spectra and agent selection 1997
 3 S2 p. 38-39
2 p.
 artikel
7 Antibiotic use 1997
 3 S2 p. 106-110
5 p.
 artikel
8 Bacterial identification 1997
 3 S2 p. 53-56
4 p.
 artikel
9 Bacterial infections in immunocompromised patients 1997
 3 S2 p. 328-334
7 p.
 artikel
10 Bacterial mechanisms for evading cellular host defences 1997
 3 S2 p. 11-12
2 p.
 artikel
11 Bartonella and Ehrlichia 1997
 3 S2 p. 342-344
3 p.
 artikel
12 Betalactam resistance in Gram-negative bacteria 1997
 3 S2 p. 300-304
5 p.
 artikel
13 Blood cultures I 1997
 3 S2 p. 49-53
5 p.
 artikel
14 Blood cultures II 1997
 3 S2 p. 262-265
4 p.
 artikel
15 Bone and joint infections 1997
 3 S2 p. 187-190
4 p.
 artikel
16 Brucella, diphtheria, leptospira 1997
 3 S2 p. 136-140
5 p.
 artikel
17 Candida infections 1997
 3 S2 p. 304-307
4 p.
 artikel
18 Chlamydia and ureaplasma 1997
 3 S2 p. 272-277
6 p.
 artikel
19 Clinical value of rapid results in microbiology 1997
 3 S2 p. 13-14
2 p.
 artikel
20 Clostridium difficile 1997
 3 S2 p. 218-220
3 p.
 artikel
21 Computer analysis of microbial molecular typing data (ESCMID European Study Group on Epidemiological Markers) 1997
 3 S2 p. 37-
1 p.
 artikel
22 Cytomegalovirus 1997
 3 S2 p. 248-253
6 p.
 artikel
23 Detection and identification of fungi 1997
 3 S2 p. 75-79
5 p.
 artikel
24 Diagnosis and treatment of lower respiratory tract infections 1997
 3 S2 p. 313-318
6 p.
 artikel
25 Diagnostic mycobacteriology 1997
 3 S2 p. 25-26
2 p.
 artikel
26 Endothelium and microbial interactions (Joint Symposium with the Infectious Diseases Society of America) 1997
 3 S2 p. 39-40
2 p.
 artikel
27 Endotoxin and sepsis 1997
 3 S2 p. 201-205
5 p.
 artikel
28 Epidemiology and resistance in pneumococci and other Gram-positive cocci 1997
 3 S2 p. 289-294
6 p.
 artikel
29 Epidemiology of antibiotic resistance I 1997
 3 S2 p. 69-75
7 p.
 artikel
30 Epidemiology of antibiotic resistance II 1997
 3 S2 p. 175-180
6 p.
 artikel
31 Epidemiology of bacteremia and of nosocomial infections 1997
 3 S2 p. 209-213
5 p.
 artikel
32 Epidemiology of community acquired respiratory tract infection 1997
 3 S2 p. 125-129
5 p.
 artikel
33 Epidemiology of enterococci 1997
 3 S2 p. 105-106
2 p.
 artikel
34 Epidemiology of HIV infection 1997
 3 S2 p. 152-155
4 p.
 artikel
35 Epidemiology of mycobacterial infections 1997
 3 S2 p. 310-313
4 p.
 artikel
36 Epidemiology of opportunistic infections in AIDS patients 1997
 3 S2 p. 360-365
6 p.
 artikel
37 Erratum 1997
 3 S2 p. 368-
1 p.
 artikel
38 Eurosurveillance (joint Symposium with the EuroSurveillance Editorial Board) 1997
 3 S2 p. 30-
1 p.
 artikel
39 Evaluating the evidence: What are the current and future roles for aminoglycosides? 1997
 3 S2 p. 10-11
2 p.
 artikel
40 Evidence–based choice of antibiotic therapy in ambulatory practice 1997
 3 S2 p. 18-
1 p.
 artikel
41 Evolving natural history and prognostic factors in febrile neutropenia (ESCMID Working Party on Infections in Cancer Patients) 1997
 3 S2 p. 47-48
2 p.
 artikel
42 Experimental endocarditis and meningitis 1997
 3 S2 p. 322-325
4 p.
 artikel
43 Experimental foreign body/bone infection 1997
 3 S2 p. 194-196
3 p.
 artikel
44 Fetal and neonatal infections (Joint Symposium with the European Society for Paediatric Infectious Diseases) 1997
 3 S2 p. 8-
1 p.
 artikel
45 Foreign body associated infections 1997
 3 S2 p. 34-35
2 p.
 artikel
46 From tick to man: An examination of Lyme disease in Europe 1997
 3 S2 p. 5-6
2 p.
 artikel
47 Fungal infections II 1997
 3 S2 p. 307-310
4 p.
 artikel
48 Fungal infections in cancer patients 1997
 3 S2 p. 334-337
4 p.
 artikel
49 Gastrointestinal infections 1997
 3 S2 p. 220-225
6 p.
 artikel
50 General infection control issues 1997
 3 S2 p. 110-112
3 p.
 artikel
51 Gene therapy: Where do we stand? 1997
 3 S2 p. 46-47
2 p.
 artikel
52 Glycopeptides for enterococci and other Gram-positive cocci I 1997
 3 S2 p. 95-98
4 p.
 artikel
53 Glycopeptides for enterococci and other Gram-positive cocci II 1997
 3 S2 p. 170-175
6 p.
 artikel
54 Grepafloxacin – A new quinolone designed for respiratory tract infection 1997
 3 S2 p. 1-
1 p.
 artikel
55 Helicobacter pylori 1997
 3 S2 p. 225-233
9 p.
 artikel
56 Heliobacter pylori–within and beyond the digestive tract (European Heliobacter pylori Study Group) 1997
 3 S2 p. 23-24
2 p.
 artikel
57 Hepatitis A 1997
 3 S2 p. 233-235
3 p.
 artikel
58 Hepatitis B and miscellaneous 1997
 3 S2 p. 235-239
5 p.
 artikel
59 Hepatitis C 1997
 3 S2 p. 239-245
7 p.
 artikel
60 Hepatitis G 1997
 3 S2 p. 246-247
2 p.
 artikel
61 Herpes viruses (HSV, VZV, EBV and HHV-6) 1997
 3 S2 p. 351-356
6 p.
 artikel
62 Host defenses and immune response 1997
 3 S2 p. 196-201
6 p.
 artikel
63 Identification of Gram-positive bacteria 1997
 3 S2 p. 56-59
4 p.
 artikel
64 Infection in the organ transplant patient: A modern Hegelian dialectic (Joint Symposium with the International Immunocompromised Host Society) 1997
 3 S2 p. 27-28
2 p.
 artikel
65 Infections in the elderly 1997
 3 S2 p. 4-
1 p.
 artikel
66 Infective endocarditis and vascular infections 1997
 3 S2 p. 134-136
3 p.
 artikel
67 Influenza and pneumococcal vaccination for older adults in Western Europe 1997
 3 S2 p. 40-41
2 p.
 artikel
68 Innovative strategies for prevention and treatment of septic shock (Joint symposium with the European Society of Intensive Care Medicine) 1997
 3 S2 p. 20-
1 p.
 artikel
69 Intravascular infections related to devices 1997
 3 S2 p. 118-121
4 p.
 artikel
70 Latest lessons from experimental models (ESCMID European Network for the Study of Experimental Infections) 1997
 3 S2 p. 47-
1 p.
 artikel
71 Luminal and tissular protozoans 1997
 3 S2 p. 182-184
3 p.
 artikel
72 Lyme borreliosis 1997
 3 S2 p. 140-146
7 p.
 artikel
73 Macrolides, streptogramins and miscellaneous antibiotics 1997
 3 S2 p. 285-289
5 p.
 artikel
74 Malaria 1997
 3 S2 p. 180-182
3 p.
 artikel
75 Management of opportunistic infections in immunocompromised patients: International Immunocompromised Host Society 1997
 3 S2 p. 1-
1 p.
 artikel
76 Mechanisms of antibiotic resistance in Gram-positive bacteria 1997
 3 S2 p. 65-69
5 p.
 artikel
77 Mediators of inflammation 1997
 3 S2 p. 205-209
5 p.
 artikel
78 Meningitis: Epidemiology and complications 1997
 3 S2 p. 318-322
5 p.
 artikel
79 Methicillin-resistant staphlylococci 1997
 3 S2 p. 98-105
8 p.
 artikel
80 Methods for drug susceptibility testing of bacteria 1997
 3 S2 p. 59-65
7 p.
 artikel
81 Methods for drug susceptibility testing of Gram-positive bacteria 1997
 3 S2 p. 155-158
4 p.
 artikel
82 Miscellaneous experimental infections 1997
 3 S2 p. 325-328
4 p.
 artikel
83 Miscellaneous infections 1997
 3 S2 p. 149-152
4 p.
 artikel
84 Miscellaneous infections in HIV patients 1997
 3 S2 p. 366-367
2 p.
 artikel
85 Miscellaneous viruses 1997
 3 S2 p. 358-360
3 p.
 artikel
86 Miscelloneous infections in cancer patients 1997
 3 S2 p. 337-340
4 p.
 artikel
87 Molecular diagnosis of tuberculosis 1997
 3 S2 p. 158-162
5 p.
 artikel
88 Molecular fungal diagnosis and resistance 1997
 3 S2 p. 82-83
2 p.
 artikel
89 Molecular methods for the diagnosis of infectious diseases (ESCMID European Study Group on Molecular Diagnostics) 1997
 3 S2 p. 34-
1 p.
 artikel
90 Molecular pathogenesis of Staphylococcus aureus infection 1997
 3 S2 p. 3-4
2 p.
 artikel
91 Multiresistant pathogens: The case of non–fermentative Gram–negative bacilli 1997
 3 S2 p. 46-
1 p.
 artikel
92 Mycobacteria: Susceptibility and resistance 1997
 3 S2 p. 265-269
5 p.
 artikel
93 Neonatal and paediatric nosocomial infections 1997
 3 S2 p. 121-124
4 p.
 artikel
94 New aspects of anaerobic bacterial infections (ESCMID European Working Party on Antimicrobial Resistance in Anaerobic Bacteria) 1997
 3 S2 p. 31-32
2 p.
 artikel
95 New automated methods for identification and antimicrobial susceptibility testing 1997
 3 S2 p. 6-7
2 p.
 artikel
96 New Betalactams 1997
 3 S2 p. 165-170
6 p.
 artikel
97 New developments in community acquired respiratory tract infections in adults 1997
 3 S2 p. 45-
1 p.
 artikel
98 New developments in diagnostic virology 1997
 3 S2 p. 48-
1 p.
 artikel
99 New emerging viral pathogens (Joint Symposium with the International Society for Infectious Diseases) 1997
 3 S2 p. 41-42
2 p.
 artikel
100 New quinolones 1997
 3 S2 p. 30-31
2 p.
 artikel
101 New quinolones I 1997
 3 S2 p. 89-95
7 p.
 artikel
102 New quinolones II 1997
 3 S2 p. 280-285
6 p.
 artikel
103 Non molecular diagnosis of mycobacteria 1997
 3 S2 p. 163-165
3 p.
 artikel
104 Nosocomial central nervous system infections 1997
 3 S2 p. 117-118
2 p.
 artikel
105 Nosocomial infections 1997
 3 S2 p. 112-117
6 p.
 artikel
106 Old problems and new developments in the fight against the major tropical diseases (Joint Symposium with the World Health Organisation) 1997
 3 S2 p. 21-
1 p.
 artikel
107 Overview of opportunistic infections in HIV patients 1997
 3 S2 p. 36-37
2 p.
 artikel
108 Perspectives in the management of opportunistic infections in HIV infected patients 1997
 3 S2 p. 32-33
2 p.
 artikel
109 Pharmacokinetics of antibiotics 1997
 3 S2 p. 84-89
6 p.
 artikel
110 Pneumococci: The resistance challenge 1997
 3 S2 p. 42-43
2 p.
 artikel
111 Prevention strategies for Health–Care Workers (Joint Symposium with the Centers for Disease Control and Prevention, Atlanta, USA) 1997
 3 S2 p. 43-44
2 p.
 artikel
112 Progress in the prevention and treatment of chronic viral hepatitis 1997
 3 S2 p. 29-
1 p.
 artikel
113 Pseudomonas infections - cystic fibrosis 1997
 3 S2 p. 216-218
3 p.
 artikel
114 Recent advances in HIV pathogenesis 1997
 3 S2 p. 16-
1 p.
 artikel
115 Recent advances in rickettsial diseases (ESCMID European Study Group on Bartonella, Coxiella, Ehrlichia and Rickettsia) 1997
 3 S2 p. 38-
1 p.
 artikel
116 Resistant enterococci 1997
 3 S2 p. 28-29
2 p.
 artikel
117 Rickettsial infections 1997
 3 S2 p. 340-342
3 p.
 artikel
118 Selective targets for antiinfectives against bacteria (Joint Symposium with the ICAAC Program Com mittee) 1997
 3 S2 p. 6-7
2 p.
 artikel
119 Sexually transmitted diseases, papillomavirus 1997
 3 S2 p. 277-280
4 p.
 artikel
120 Short–course treatment of paediatric respiratiory tract infections 1997
 3 S2 p. 21-22
2 p.
 artikel
121 State–of–the–Art Lectures 1997
 3 S2 p. 35-
1 p.
 artikel
122 State-of-the-Art Lectures 1997
 3 S2 p. 3-
1 p.
 artikel
123 State–of–the–Art Lectures 1997
 3 S2 p. 18-
1 p.
 artikel
124 Streptococcal infections 1997
 3 S2 p. 129-134
6 p.
 artikel
125 Susceptibility testing of fungi 1997
 3 S2 p. 79-82
4 p.
 artikel
126 Susceptibility testing of yeasts 1997
 3 S2 p. 14-16
3 p.
 artikel
127 The Carbapenem Decade 1997
 3 S2 p. 24-25
2 p.
 artikel
128 The role of infections in cardiac disease (European Study Group on Cardiovascular Diseases) 1997
 3 S2 p. 13-
1 p.
 artikel
129 The role of new oral cephalosporins in rational antimicrobial therapy 1997
 3 S2 p. 9-
1 p.
 artikel
130 4th generation cephalosporins: Microbiological rationale and clinical perspectives 1997
 3 S2 p. 17-18
2 p.
 artikel
131 Tick-bome encephalitis 1997
 3 S2 p. 344-345
2 p.
 artikel
132 Towards consensus in sensitivity testing ESCMID Working Party on Antibiotic Breakpoints, Interactive Session 1997
 3 S2 p. 26-27
2 p.
 artikel
133 Towards the 21st century: Antibiotic strategies for serious infection 1997
 3 S2 p. 9-10
2 p.
 artikel
134 Toxoplasma gondii 1997
 3 S2 p. 146-149
4 p.
 artikel
135 Tracking methicillin–resistant Staphylococci 1997
 3 S2 p. 12-13
2 p.
 artikel
136 Treatment of HIV infection: Updates May 1997 1997
 3 S2 p. 19-20
2 p.
 artikel
137 Trends in nosocomial infections in Europe (ESCMID Study Group on Nosocomial Infections) 1997
 3 S2 p. 18-19
2 p.
 artikel
138 Tropical diseases and helminths 1997
 3 S2 p. 184-187
4 p.
 artikel
139 Tuberculosis: Is control under control? (Joint Symposium with the International Union Against Tuberculosis and Lung Disease) 1997
 3 S2 p. 44-45
2 p.
 artikel
140 Urinary tract infection: Laboratory diagnosis 1997
 3 S2 p. 269-272
4 p.
 artikel
141 Vaccine and immunization 1997
 3 S2 p. 345-351
7 p.
 artikel
142 Viral hemorrhagic fevers 1997
 3 S2 p. 356-358
3 p.
 artikel
143 Viral infections in solid transplant patients 1997
 3 S2 p. 253-256
4 p.
 artikel
144 Virulence factors and pathogenesis of infections 1997
 3 S2 p. 191-194
4 p.
 artikel
145 Worldwide HIV (Joint Symposium with the Joint United Nations Programme on HIV/AIDS) 1997
 3 S2 p. 4-5
2 p.
 artikel
                             145 gevonden resultaten
 
 Koninklijke Bibliotheek - Nationale Bibliotheek van Nederland